Pre-Visit Questionnaire Can Help ID Common Vestibular Diagnoses

This article originally appeared here.
Share this content:
Pre-Visit Questionnaire Can Help ID Common Vestibular Diagnoses
Pre-Visit Questionnaire Can Help ID Common Vestibular Diagnoses

WEDNESDAY, March 2, 2016 (HealthDay News) -- Use of a vestibular intake questionnaire can predict common vestibular diagnoses, prior to clinical assessment, according to research published online Feb. 25 in JAMA Otolaryngology-Head & Neck Surgery.

David R. Friedland, M.D., Ph.D., from the Medical College of Wisconsin in Milwaukee, and colleagues conducted a retrospective review of 414 consecutive new vestibular patient intake questionnaires and associated medical records to develop a statistical model for predicting vestibular diagnoses, prior to clinical evaluation.

The researchers found that 381 of the intake questionnaires had clinician information necessary to define a final diagnosis. Overall, 48 percent of the diagnoses were ear-related (103 of 183 benign paroxysmal positional vertigo [BPPV] and 49 Ménière's disease), 37 percent were neurological (109 of 141 vestibular migraine), 9 percent were medical, 2 percent were of psychological origin, 12 percent were of unknown etiology, and 9 percent had other causes. Four variables could predict diagnosis of BPPV with sensitivity and specificity of 79 and 65 percent, respectively. Five variables could predict Ménière's disease with sensitivity and specificity of 81 and 85 percent, respectively. Vestibular migraine could be predicted from four variables, with sensitivity and specificity of 76 and 59 percent, respectively.

"A pre-encounter history questionnaire can provide useful diagnostic information for common vestibular disorders," the authors write. "This can help direct appointment scheduling to improve clinical efficiency, time to intervention, and use of resources."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths